FDC
|
|
BOM : 531599     NSE : FDC     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 20,2022 |
Price(EOD): ₹ 249.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 4,207.34 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
FDC | 0.6% | -10.9% | -26.5% |
SUN PHARMACEUTICAL INDUSTRIES | 3.4% | -0.8% | 28% |
DIVIS LABORATORIES | 2.1% | -3.3% | 4.4% |
DR REDDYS LABORATORIES | 9.2% | -1.1% | -24.4% |
CIPLA | 4.9% | -3.3% | 6.1% |
GLAND PHARMA | -1.3% | -6.3% | 1% |
PIRAMAL ENTERPRISES | 2.3% | -13.7% | 12% |
CADILA HEALTHCARE | 3.5% | -0.9% | -44% |
TORRENT PHARMACEUTICALS | 3.1% | -6.9% | -4.9% |
FUNDAMENTAL ANALYSIS OF FDC
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF FDC
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
13.96
P/E Calculated based on EPS of 17.85
[ Mar2021 - Consolidated Results ] 2.43
P/B Calculated based on Book Value of 102.73
[ Mar2021 - Consolidated Results ] 2.8
P/S Calculated based on Revenues of 1500.27 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
53% -2% -3% |
SHARE PRICE MOMENTUM OF FDC
FDC vs SENSEX
DEBT OF FDC
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0 0 0 - |
0 0 0 - |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF FDC
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF FDC
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-14.04% -32.87% -44.45% -50.76% |
0.46% -35.16% -48.62% -52.66% |
QtrlyTrend |
-6 | |
Latest Qtr: Dec2021 | ||
Quarterly Result Analysis → |
FDC related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 250 SMALLCAP | 4.5% | -9.8% | 12.8% |
S&P BSE SMALL CAP | 4.1% | -8.7% | 16.8% |
S&P BSE MIDSMALLCAP | 3.7% | -8.4% | 12.6% |
S&P BSE 400 MIDSMALLCAP | 3.6% | -7.9% | 11.9% |
S&P BSE ALLCAP | 3.2% | -5.8% | 10.3% |
S&P BSE 500 | 3.2% | -5.6% | 9.7% |
S&P BSE HEALTHCARE | 2.8% | -6.4% | -4.8% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY SMALLCAP250 | 4.5% | -10% | 13.6% |
NIFTY MID SMALL400 | 3.4% | -8% | 12.5% |
NIFTY500 MULTICAP 50:25:25 | 3.4% | -6.8% | 11% |
NIFTY 500 | 3.1% | -5.7% | 9.7% |
You may also like the below Video Courses
FAQ about FDC
Is FDC good for long term investment?
As on May 20,2022, the Fundamentals of FDC look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of FDC . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is FDC UnderValued or OverValued?
As on May 20,2022, FDC is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of FDC ?
As on May 20,2022, the Intrinsic Value of FDC is Rs. 255.43 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 163.14
Fair Value [Median EV / Sales Model] : Rs. 255.43
Fair Value [Median Price / Sales Model] : Rs. 255.82
Median Fair Value of FDC : Rs. 255.43
Is FDC trading at a Premium or Discount?
As on May 20,2022, FDC is trading at a Discount of -2% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
